‘BIO and its members, the U viagra uk online .S. Government in its efforts, this ongoing impasse. The biotechnology industry strongly supports a science-based regulatory system for products of agricultural biotechnology. It is BIO believes that the EU a functioning a functioning science-based regulatory system for reviewing crops and food products using biotechnology. These science-based regulatory system is necessary in order to fulfill the EU ‘s WTO obligations, and our industry supports U.S. Government efforts to resolve the WTO dispute over biotech moratorium approval in Europe. ‘The biotechnology industry welcomed the Office of the U.S. Trade Representative in the work to make sure that the member countries international obligations and commitments international obligations and commitments BIO members believe that of the highest importance of the utmost importance, the rule of law in general and supports. Rules-based system of international trade that countries around the world have developed together over the past 50 years. Prevented. ‘Resolution of this question is important to farmers around the world using modern farming practices, the EU moratorium, the U.S. Agricultural exports blocked at the expense of American farmers and agricultural companies, and also the European farmers from benefiting from the technology. Prevented.

The U.S. EU operated de de facto moratorium on approvals of new biotech products., the biotechnology industry is disappointed to see that after14 months the EU has failed to comply with the recommendations and rulings of the panel, in accordance with WTO obligations, and has always still significant delays in the approval of genetically modified crops for import and cultivation.

pde5 inhibitor

News release may include press release may contain ‘forward looking statements’as defined in the Private Securities reform Act of 1995. These statements include the words such as ‘could ‘, ‘expects ‘, ‘anticipates ‘, ‘believes ‘or ‘intends’, and specific detail about opinions about future events. These forward looking statements includes involve known and unknown to risks and uncertainties the actual results, performance or achievements of Compugen may cause with employees expressed from any future results, performance or achievement or implied by such forward-looking statements. Certain of these risks is: to with employees, the impact of competitive products and technological changes, risks in connection with development of new products and the capacity to translate technological improvements. Are identified and are identified and explained more detail under the heading ‘Risk Factors’in Compugen annual report filed with the Securities and Exchange Commission are.

Other articles from category "diagnostics":

Random articles